The efficacy and safety of selective H1-antihistamine versus leukotriene receptor antagonist for seasonal allergic rhinitis: a meta-analysis.
Both selective H1-antihistamine (SAH) and leukotriene receptor antagonist (LTRA) have been shown to be effective in treating patients with seasonal allergic rhinitis (SAR), but it is still uncertain which treatment option is optimal. This meta-analysis was aimed to compare the efficacy and safety of...
Main Authors: | Yu Xu, Jixiang Zhang, Jun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4226613?pdf=render |
Similar Items
-
Comparative Study to Assess Clinical Efficacy of Leukotriene Receptor Antagonist and Antihistamines in the Treatment of Allergic Rhinitis
by: Gurpreet Kaur, et al.
Published: (2017-08-01) -
Comparative Study to Assess Clinical Efficacy of Leukotriene Receptor Antagonist and Antihistamines in the Treatment of Allergic Rhinitis
by: Gurpreet Kaur, et al.
Published: (2017-08-01) -
Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence
by: Yan Feng, et al.
Published: (2021-06-01) -
A Comparison of Intranasal Corticosteroid, Leukotriene Receptor Antagonist, and Topical Antihistamine in Reducing Symptoms of Perennial Allergic Rhinitis as Assessed through the Rhinitis Severity Score
by: Niti Sardana M.S., et al.
Published: (2010-01-01) -
Therapeutic Effect of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, on Japanese Patients with Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)